These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 467803)

  • 21. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S; Tanimoto T; Kurata T
    Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparative isolation of myxovirus glycoproteins and the study of their immunogenic properties].
    Berezin VE; Zaĭdes VM; Mchedlishvili BV; Selimova LM; Kliushnik SIu
    Mol Gen Mikrobiol Virusol; 1985 Jul; (7):36-43. PubMed ID: 3025716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparative isolation of basic structural proteins of the influenza virus].
    Ksenofontov AL; Fedorova NV; Glushakova SE
    Mol Gen Mikrobiol Virusol; 1992; (3-4):3-6. PubMed ID: 1406760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns.
    Kalashnikova I; Ivanova N; Tennikova T
    Anal Chem; 2008 Mar; 80(6):2188-98. PubMed ID: 18271603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions.
    Crawford CR; Mukhlis FA; Jennings R; Oxford JS; Hockley DJ; Potter CW
    Vaccine; 1984 Sep; 2(3):193-8. PubMed ID: 6531961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and function of influenza A virus glycoproteins.
    Scholtissek C
    Behring Inst Mitt; 1991 Jul; (89):46-53. PubMed ID: 1930103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some characteristics of Sendai virus envelope solubilization by different detergents.
    Tomas E; Samuel I; Istodor A; Bârnaure F; Kharitonenkov I; Zakomyrdin I
    Virologie; 1982; 33(1):53-7. PubMed ID: 6280374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.
    Tanimoto T; Nakatsu R; Fuke I; Ishikawa T; Ishibashi M; Yamanishi K; Takahashi M; Tamura S
    Vaccine; 2005 Aug; 23(37):4598-609. PubMed ID: 15964668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple and rapid separation of ortho- and paramyxovirus glycoproteins.
    Bosch FX; Mayer A; Huang RT
    Med Microbiol Immunol; 1980; 168(4):249-59. PubMed ID: 7442614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of the cationic detergent dodecyltrimethylammonium bromide for the isolation of influenza virus glycoproteins with subsequent integration of the protein into liposome membrane].
    Glushakova SE; Naroditskiĭ BS; Tikhonenko TI; Klibanov AL; Torchilin VP
    Mol Gen Mikrobiol Virusol; 1985 Apr; (4):39-44. PubMed ID: 3842749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Virology; 1976 Feb; 69(2):511-22. PubMed ID: 1258359
    [No Abstract]   [Full Text] [Related]  

  • 38. Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.
    van Wezel AL; van Herwaarden JA; van de Heuvel-de Rijk EW
    Dev Biol Stand; 1979; 42():65-9. PubMed ID: 223923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of non-infectious hemagglutinating particles of rabies virus and isolation of the hemagglutinin by disruption of the virion with Nonidet P-40.
    Arai YT; Kondo A; Suzuki K
    Arch Virol; 1976; 51(4):335-45. PubMed ID: 973800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of the glycoproteins of vaccinal strains of the influenza viruses solubilized by octyl-beta-D-glucopyranoside].
    Mel'nikov SK; Busygina OG; Shekut'eva NA; Reĭngol'd VN; Chumakov MP
    Vopr Virusol; 1985; 30(2):153-8. PubMed ID: 4002689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.